CA
NZ
UK
AU
IND
US
Richard M. Schulze, Chairman Emeritus of Best Buy Co Inc, filed a Form 4 on November 9, 2026, disclosing a change in beneficial ownership of common stock resulting from the appointment of his spouse as trustee of a trust on November 5, 2026.
Carlos Nueno, President, International at Teladoc Health, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 29,432 shares of common stock on November 6, 2026, under a pre-established Rule 10b5-1 trading plan.
Director and 10% owner Edgar R. Smith III filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 5,000 shares of First Guaranty Bancshares, Inc. common stock on November 6, 2026.
A Form 4 filed on November 9, 2026 reports that Beth Bruce Witte, a director of Slide Insurance Holdings, Inc. (NASDAQ:SLDE), sold 25,000 shares of common stock on November 5, 2026 through the Beth W. Bruce Witte Family 1992 Trust.
Juan Andres, Chief Operating Officer of Moderna, Inc., filed a Form 4 on November 9, 2026, disclosing the acquisition of stock options and restricted stock units on November 5, 2026 under NASDAQ:MRNA.
Director Joel Ackerman of Champions Oncology, Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of options to purchase 31,216 shares of common stock on November 5, 2026.
Carl Russo, a director and 10% owner of Calix, Inc. (NYSE:CALX), filed a Form 4 on November 9, 2026, disclosing the sale of 75,000 shares of common stock on November 6, 2026, pursuant to a Rule 10b5-1 trading plan.
Director and 10% owner Scott R. Tobin filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of stock options to purchase common stock of Champions Oncology, Inc. (NASDAQ:CSBR), with the earliest transaction date of November 5, 2026.
Director Daniel Newman Mendelson filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of options to purchase common stock of Champions Oncology, Inc. (NASDAQ:CSBR), with the earliest transaction date of November 5, 2026.
Director Michelle T. Collins of Owens Corning filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 479 shares of common stock on November 6, 2026, as the share portion of her quarterly director retainer and fees.
Please wait processing your request...